1824707-75-6
中文名稱
化合物 T30275
英文名稱
Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate, compd. with 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate (1:1:1)
CAS
1824707-75-6
分子式
C55H53N9O11
分子量
1016.08
MOL 文件
1824707-75-6.mol
1824707-75-6 結(jié)構(gòu)式
基本信息
中文別名
化合物 T30275 英文別名
Azilsartan trimethylethanolamineEthanaminium, 2-hydroxy-N,N,N-trimethyl-, 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate, compd. with 1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate (1:1:1)
應(yīng)用領(lǐng)域
用途一
Azilsartan is an angiotensin II receptor antagonist used in the treatment of hypertension, developed by Takeda. It is marketed in tablet form under the trade name Edarbi as the prodrug azilsartan medoxomil (INN, codenamed TAK-491). Azilsartan medoxomil lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone.